These genes included GRX480 as part of a generalized effect on JA-associated genes, while ROXY1 or ROXY2 expression were not affected (Mhamdi et al., 2010a)
Direct-to-Consumer (DTC) Weight-Loss Medication Market Size, Share & Trends Analysis Report By Drug Type (Prescription Medications, OTC Medications, Herbal and Natural Supplements), By Route of Administration (Oral, Injectable, Others), By Distribution Channel (Online Pharmacies, Drug Stores & Retail Pharmacies, Direct Brand websites) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034 Last Updated: July 24, 2026 | Author: Debashree B | Format: | Report Code: SR7264DR | Pages: 110 Direct-to-Consumer (DTC) Weight-Loss Medication Market Size & Growth Analysis The global direct-to-consumer (DTC) weight-loss medication market size is valued at USD 8.64 billion in 2025 and is estimated to reach USD 35.61 billion by 2034, growing at a CAGR of 17.08% during the forecast period
Decreased Pulse: The pulse in the feet or legs may be weak or absent, particularly in advanced cases of PAD
Pharmacokinetic and Toxicity Parameters of Novel Antiplasmodial Lead Compounds Early evaluation of drug-likeness helps select the best leads during drug discovery and development